CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,051 | -31.8% | 154,310 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $25,000 | -35.9% | 154,310 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $39,000 | -52.4% | 154,310 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $82,000 | -13.7% | 154,310 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $95,000 | -77.5% | 154,310 | -62.7% | 0.00% | -78.6% |
| Q3 2021 | $422,000 | -44.3% | 413,481 | 0.0% | 0.01% | -44.0% |
| Q2 2021 | $757,000 | -7.1% | 413,481 | 0.0% | 0.02% | -10.7% |
| Q1 2021 | $815,000 | +57.6% | 413,481 | 0.0% | 0.03% | +55.6% |
| Q4 2020 | $517,000 | -30.5% | 413,481 | 0.0% | 0.02% | -35.7% |
| Q3 2020 | $744,000 | -76.6% | 413,481 | +9.2% | 0.03% | -76.9% |
| Q2 2020 | $3,177,000 | – | 378,706 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |